Zamann Pharma Support logo

Siedlerstraße 7 | 68623 Lampertheim, Germany

info@zamann-pharma.com

Request an appointment now

Innovations and highlights in the Pharma industry 

Dive deep into the world of Pharma with Zamann’s Expert Blog. Our industry-leading professionals share insights on global project management, quality consultancy, digitalization, and more. Stay updated with trends and innovations transforming the Pharma industry. 

News and more

Manufacturing Readiness Is Reshaping Pharma M&A; Why GMP Due Diligence Now Drives Deal Decisions

Pharmaceutical dealmaking slowed during the first half of 2026, yet industry experts say transaction quality has become more important than volume. Speaking with Pharmaceutical Technology, KPMG US Life Sciences Sector Leader Kristin Ciriello Pothier explained that manufacturers now place greater
  • News
Manufacturing Readiness Is Reshaping Pharma M&A; Why GMP Due Diligence Now Drives Deal Decisions

Jaypirca Wins CHMP Support; Why Europe Is Moving Toward All-Line CLL Treatment

The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended Eli Lilly’s Jaypirca (pirtobrutinib) for approval to treat adults with chronic lymphocytic leukemia (CLL) across all lines of therapy, regardless of previous BTK inhibitor treatment. The
  • News
Jaypirca Wins CHMP Support; Why Europe Is Moving Toward All-Line CLL Treatment

Equipment Qualification In Pharma in 2026: GMP Compliance Risks, Validation Failures, and Inspection Findings

Learn how pharmaceutical equipment qualification supports GMP compliance, inspection readiness, and lifecycle control. Explore common qualification failures, IQ OQ PQ qualification practices, requalification triggers, and equipment lifecycle management strategies that help reduce regulatory risk and inspection findings.
  • Blog, Validation and Qualification
Pharmaceutical equipment qualification process showing installation qualification, operational qualification, performance qualification, and equipment lifecycle management in a GMP manufacturing facility

Area Qualification In Pharma In 2026: HVAC Qualification, Cleanroom Control, and GMP Compliance Systems

Area qualification helps pharmaceutical manufacturers maintain cleanroom performance, HVAC effectiveness, and environmental control throughout the facility lifecycle. This guide explains qualification requirements, inspection risks, contamination control strategies, and ongoing activities that support GMP compliance and inspection readiness.
  • Blog, Validation and Qualification
GMP facility qualification with cleanroom classification, HVAC validation, environmental monitoring systems, and controlled manufacturing environments.

pharma qualification in 2026: GMP Failures, Validation Gaps, and Inspection Findings

This article explains pharma qualification as a GMP-controlled lifecycle covering equipment, facilities, and utilities. It highlights inspection findings, validation gaps, and regulatory expectations from FDA and EU GMP authorities, focusing on real-world compliance risks and system failures.
  • Blog, Validation and Qualification
Pharma qualification lifecycle and GMP validation concepts including IQ OQ PQ equipment qualification and data integrity requirements in pharmaceutical manufacturing systems

Mayo Clinic Reveals Hidden Limits; AI Can’t Fully Automate Revenue Cycles

Mayo Clinic is applying artificial intelligence across its revenue cycle operations to streamline repetitive administrative workflows, while maintaining human oversight in clinical and billing decisions. Revenue cycle chair Todd Manion shared these insights during an interview at HFMA’s annual conference
  • News
Mayo Clinic Reveals Hidden Limits; AI Can’t Fully Automate Revenue Cycles

FDA Data Sharing Mandate Escalates; CGT Industry Faces System-Wide Transparency Shift

The cell and gene therapy (CGT) industry is facing growing pressure to transform how it develops, manufactures, and commercializes advanced therapies, according to industry experts speaking ahead of BIO 2026. In discussions highlighted by BioSpace on June 22, 2026, leaders
  • News
FDA Data Sharing Mandate Escalates; CGT Industry Faces System-Wide Transparency Shift

pharma regulatory bodies in 2026: FDA, EMA, WHO Roles, and Global GMP Control Systems

This article explores how pharma regulatory bodies such as FDA, EMA, and WHO shape global GMP compliance. It highlights inspection trends, data integrity requirements, and harmonized regulatory frameworks that drive pharmaceutical quality systems and inspection readiness worldwide.
  • Blog, Validation and Qualification
Illustration of FDA, EMA, and WHO regulatory bodies overseeing global GMP inspection readiness, pharmaceutical quality systems, and data integrity requirements in international drug regulatory frameworks.